Despite clear public opinion to the contrary, progressives in Congress are eager to eliminate even the weak regulations that prevent a chaotic explosion of research into genetic engineering of human embryos. Hidden away in a House appropriations agriculture subcommittee, Democrats in May repealed the spending bill rider that prohibited the FDA from considering requests to approve any clinical trial “in which a human embryo is intentionally created or modified to include a heritable genetic modification.” Republicans forced the rider to be reinstated on June 4 in the full Appropriations Committee, but its long-term fate remains uncertain. The headlong pursuit of genetic engineering therapies flies in the face of the American public’s views. An AP-NORC poll last year found that only around 10% of Americans, even without prior education about the potential dangers to individuals and future generations, favored genetically altering embryos to change physical...(Read Full Article)